Sign up
Log in
Utah Medical Products 2Q FY26 net income drops 11.9% to USD 2.69 million; revenue falls 14.3% to USD 8.53 million
Share
Listen to the news
Utah Medical Products 2Q FY26 net income drops 11.9% to USD 2.69 million; revenue falls 14.3% to USD 8.53 million
  • Utah Medical Products reported 2Q 2026 net income of USD 2.69 million, down 11.9% year over year; diluted EPS fell 10.1% to USD 0.84.
  • Revenue dropped 14.3% to USD 8.53 million, reflecting no revenue from PendoTECH or its former China distributor.
  • Operating income declined 17.1% to USD 2.65 million, pressured by USD 213,000 higher U.S. litigation costs.
  • For 1H 2026, net income decreased 13.1% to USD 5.29 million on a 12.3% revenue slide to USD 17.25 million.
  • Management now expects a 10%-13% full-year 2026 revenue decline versus 2025, citing slower-than-expected new biopharma OEM customer sales.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Utah Medical Products Inc. published the original content used to generate this news brief via ACCESS Newswire (Ref. ID: 202607230900ACCESSWRNAPR_____1195225) on July 23, 2026, and is solely responsible for the information contained therein.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending
Terms of Service·Privacy Policy·Data Disclaimer
No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.
Copyright © 2026 Webull. All Rights Reserved